ARYA Sciences Acquisition Corp IV
ARYDNASDAQFinancial Services·US · USD
$0.68
-0.05 (-6.63%)
Prices as of August 7, 2026 · livePrice
Key statistics
Valuation
Market cap5.42M USD
Enterprise value0.00 USD
Trailing P/E188.17
Forward P/E0.00
PEG ratio-0.47
Price / sales0.00
Price / book0.26
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-5.25%
Return on equity-8.31%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income-2.13M USD
Diluted EPS-$0.22
Rev. growth (YoY)0.00%
Balance sheet
Total cash87.50K USD
Total debt0.00 USD
Debt / equity0.00
Current ratio0.01
Book value / share$2.89
Cash flow (TTM)
Operating cash flow-4.69M USD
Levered free cash flow-2.13M USD
Shares & price
Shares outstanding7.54M
Float0.00
Held by institutions0.00%
Beta0.00
50-day MA$0.00
200-day MA$0.00
52-week high$2.58
52-week low$0.36
About ARYA Sciences Acquisition Corp IV
Arya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors. The company was incorporated in 2020 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Mr. Adam Leo Stone
- Headquarters
- New York, NY, United States
- Website
- www.perceptivelife.com/arya4